Amgen Inc.
$AMGN
Public valuation for Amgen Inc. (AMGN). Fair value, signal, and key metrics — no sign-in required.
Current Price
$429.88
24% Undervalued
Fair Value Estimate
$533
🏛️
Mature Growth
Profitable company with steady growth
Analyst Consensus
Target: $388.48
10% lower than current
Key Metrics
Market Cap
$232.4B
Forward P/E
19.5x
Operating Margin
34.9%
Revenue Growth
8.0%
PEG Ratio
5.48
Get free watchlist alerts
Join the waitlist for valuation updates on $AMGN and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.